Menu

Search

Aaron Yin

Aaron Yin

Associate, Health & Aged Care Program, Grattan Institute
Aaron is an Associate in Grattan Institute’s Health and Aged Care Program. He previously worked at the Victorian Department of Health on projects related to mental health, digital health, and strategic commissioning.

He holds a Bachelor of Biomedicine and Master of Public Health from the University of Melbourne.

1 

Economy

BoJ Rate Hike Odds Rise as Tokyo Inflation Surges Beyond Expectations

Tokyos consumer inflation surged in April, reinforcing expectations that the Bank of Japan (BoJ) may raise interest rates sooner than anticipated. According to ING analysts, a sharper-than-expected rise in Tokyos core...

Gold Prices Rebound as U.S.-China Tensions and Russia-Ukraine Conflict Fuel Safe Haven Demand

Gold prices surged in Asian trading Thursday, bouncing back from earlier losses as uncertainty over the U.S.-China trade war and renewed Russia-Ukraine tensions boosted demand for safe haven assets. Spot gold rose 1.3% to...

Thailand’s Exports Surge to 3-Year High Despite U.S. Tariff Risks

Thailands exports jumped 17.8% year-on-year in March, marking the ninth consecutive monthly increase and the highest level in three years, according to the Commerce Ministry. The figure outperformed analysts expectations...

FxWirePro- Major Economic Events for the day

Time Currency Detail Actual Forecast Previous 2:30am AUD RBA...

Malaysia Weighs Growth Forecast Cut as U.S. Tariff Deadline Looms

Malaysia is likely to lower its 2025 GDP growth forecast of 4.5% to 5.5% due to rising trade tensions and looming U.S. tariffs, according to Bank Negara Malaysia Governor Abdul Rasheed Ghaffour. Speaking at an IMF event in...

Politics

China Urges Global Cooperation Amid Weak Economic Growth at G20 Meeting

Chinas Finance Minister Lan Foan warned that the global economy faces weakening growth momentum, worsened by ongoing tariff and trade disputes. Speaking at a G20 finance ministers meeting in Washington, Lan emphasized the...

Ramaphosa Urges Unconditional Ukraine-Russia Peace Talks During Zelenskiy Visit

South African President Cyril Ramaphosa called for peace talks between Ukraine and Russia to begin without any preconditions, including the controversial idea of Ukraine ceding territory to Moscow. His remarks came during...

Trump Urges Putin to Halt Missile Strikes on Kyiv, Calls Timing "Very Bad"

U.S. President Donald Trump issued a rare rebuke of Russian President Vladimir Putin on Thursday, urging him to stop missile and drone strikes on Kyiv. Vladimir, STOP! Trump wrote in a social media post following Russias...

Modi Vows Retaliation After Deadly Kashmir Attack, India Cuts Ties with Pakistan

Indian Prime Minister Narendra Modi has vowed to hunt down the perpetrators of a deadly militant attack in Kashmir that killed 26 tourists, calling it the worst civilian assault in nearly two decades. Speaking at a rally...

Japan’s Economy Minister Heads to U.S. for Crucial Tariff Negotiations

Japans Economy Minister Ryosei Akazawa is set to travel to Washington from April 30 to May 2 for a second round of high-stakes negotiations with U.S. officials regarding tariffs on Japanese exports, according to media...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Baidu Launches Advanced Ernie AI Models to Compete in China’s Growing AI Race

Baidu (NASDAQ:BIDU) has launched upgraded versions of its Ernie artificial intelligence models, intensifying its push in Chinas fast-evolving AI landscape. At a developer conference held in Wuhan, CEO Robin Li introduced...

South Korea Flags DeepSeek for Unauthorized Data Transfers to China and U.S.

South Koreas Personal Information Protection Commission (PIPC) has accused Chinese AI startup DeepSeek of transferring personal user data and prompt content without consent during its app launch in January 2025. The PIPC...

Adobe Expands Firefly with AI from OpenAI and Google, Launches Mobile App

Adobe (NASDAQ:ADBE) is expanding its Firefly generative AI service by integrating image-generation models from OpenAI and Google (NASDAQ:GOOGL), while also making the app available on mobile devices. This move...

Nintendo Switch 2 Sees Surging Demand with 2.2 Million Lottery Applications in Japan

Nintendo has revealed that over 2.2 million people have entered a lottery for the new Switch 2 console in Japan, signaling overwhelming demand ahead of its June 5 launch. The company admitted it cannot fulfill all orders...

TSMC to Launch Advanced 1.4nm Chips by 2028 to Power AI Growth

Taiwan Semiconductor Manufacturing Company (TSMC), the worlds leading contract chipmaker and a key supplier to Nvidia (NASDAQ:NVDA), announced plans to begin mass production of its next-generation 1.4 nanometer (nm) chip...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.